Segment Reporting (Tables)

3 Months Ended

Mar. 31, 2014

Segment Reporting Information By Segment

A reconciliation of the totals reported for the reportable segments to the applicable line items in our accompanying unaudited condensed consolidated statements of operations is as follows:



	Three Months Ended March 31,
(in millions)	2014			2013
				(restated)
Net sales
Interventional Cardiology	$	501		$	498
Peripheral Interventions	204			193
Cardiovascular	705			691

Cardiac Rhythm Management	464			475
Electrophysiology	58			34
Rhythm Management	522			509

Endoscopy	316			300
Urology and Women's Health	126			117
Neuromodulation	109			89
MedSurg	551			506
Net sales allocated to reportable segments	1,778			1,706
Sales generated from divested businesses	2			36
Impact of foreign currency fluctuations	(6		)	19
	$	1,774		$	1,761

Income (loss) before income taxes
Cardiovascular	$	171		$	158
Rhythm Management	66			57
MedSurg	168			140
Operating income allocated to reportable segments	405			355
Corporate expenses and currency exchange	(50		)	(42		)
Goodwill and other intangible asset impairment charges; and acquisition-, divestiture-, restructuring-, and litigation related charges or credits	(49		)	(540		)
Amortization expense	(109		)	(103		)
Operating income (loss)	197			(330		)
Other expense, net	(51		)	(64		)
Income (loss) before income taxes	$	146		$	(394	)

- Definition

Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.

+ References+ Details